Dexanabinol

Dexanabinol, also known under the designations HU-211 or ETS210, is a synthetic derivative of cannabinoids. Distinct from the majority of cannabinoid derivatives, Dexanabinol represents the "unnatural" enantiomer of the influential cannabinoid agonist HU-210. Its unique properties set it apart from the conventional effects observed with many cannabinoid compounds.

Pharmacological Action

Unlike most cannabinoids, HU-211 doesn't function as a cannabinoid receptor agonist. Instead, it exerts its effects primarily as an NMDA antagonist. As such, it doesn't mimic the typical cannabis-induced outcomes.

Neuroprotective and Anticonvulsant Properties

Dexanabinol demonstrates significant anticonvulsant and neuroprotective properties. These characteristics make it an area of keen interest in scientific research, especially in studies focusing on neural health and protection.

Therapeutic Potential

The unique properties of Dexanabinol make it a candidate for various therapeutic applications:

Brain Injury or Stroke: Given its neuroprotective characteristics, Dexanabinol is being studied for its potential in treating conditions like brain injuries or strokes, where neural protection is crucial.
Cancer Treatment: Preliminary research indicates potential applications of Dexanabinol in the treatment of certain types of cancers, particularly brain cancer.
Anticonvulsant: Its anticonvulsant properties are also being explored for applications in conditions like epilepsy or other seizure-related disorders.

Clinical Trials

Dexanabinol has successfully passed the safety checks in clinical trials. It's currently undergoing Phase I trials, primarily focusing on its effectiveness and applicability in the treatment of brain cancer.

Mechanism of Action

Dexanabinol’s primary mechanism doesn't revolve around the cannabinoid receptors. Instead, its action as an NMDA antagonist has intrigued researchers, leading to multiple studies on its potential benefits.

- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.

NYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC

Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.